Indian Army Medical Supplies Tender 2025: ISI/ISO-Grade Medicines and Injections Procurement Rajasthan/India

Tender Overview

The Indian Army under the Department Of Military Affairs invites bids for a broad catalog of pharmaceutical and medical consumables, including injectable drugs, oral tablets, infusions, ophthalmic solutions, topical creams, and gloves. The procurement covers 43 items spanning anaesthetics, analgesics, antibiotics, antiemetics, sedatives, anti-hypertensives, diuretics, insulin products, and rehydration solutions. The contract quantity is adjustable by up to 25% more or less during and after award, with the extension timeframe governed by the delivery period logic. The scope emphasizes continuity of supply to meet field and hospital requirements, with emphasis on standard-compliant, ready-to-use pharmaceuticals. The tender’s unique clauses include demurrage penalties for non-lifted stock and a detailed inspection/appeal framework, ensuring quality and traceability. Location specifics are not disclosed in the data provided, but the organizational context remains the Indian Army’s medical supply chain, with a focus on reliable, compliant medical consumables for immediate deployment readiness.

Technical Specifications & Requirements

• Items include a wide range: injectable drugs (e.g., antiarrhythmics, vasopressors), parenteral infusions (e.g., 100 ml bottles), tablets/capsules (e.g., analgesics, antibiotics, sedatives), topicals (creams, gels), and related medical aids (Troponin T test card, Dextrose injections, saline solutions).
• No explicit numeric technical specs were provided in the data; the bid emphasizes common pharmaceutical category compliance, with a robust inspection workflow and an appeal mechanism for rejected stocks.
• Notable compliance terms include inspection verdicts by CFL, acceptance sample testing, and an appeal process to ST-7/8 DGST and QMG’s Branch, with timelines for sample submission and formal decisions.
• The tender contemplates bulk/periodic delivery, contingent upon the option clause, and a minimum 30-day delivery baseline when the quantity is increased.

Terms, Conditions & Eligibility

• Option Clause: Purchaser may adjust contract quantity by up to 25% during and after award; extended delivery time scales as (Additional quantity ÷ Original quantity) × Original delivery period, min 30 days.
• Demurrage: If rejected items are not lifted within 48 hours, demurrage at 0.5% of total contract value per day; items unlifted for a month may be destroyed with no claim.
• Inspection/Quality: Samples called “Acceptance samples”; CFL verdict drives stock rejection; vendor may appeal within 14 days to the specified testing authorities.
• Additional documents and explicit submission requirements are derived from standard tender terms (GST, PAN, experience, EMD, OEM authorizations) as applicable to government medical procurements.